Skip to content
DataLookout
Menu

NCT05124951

The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell Tumors

StatusUnknown
PhasePhase 2
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Nov 2021); last known: Recruiting
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

3-year event-free survival
Timeframe: From the enrollment to the event (relapse or death of any cause), approximately 3 years. The patients will receive long-term follow-up including MRI and serum tumor markers examination every 3 months until 36 months.
Change of score of the QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales, Chinese edition)
Timeframe: Score will be obtained at baseline, 6 months posttreatment, yearly through 3 years posttreatment
Change of score of the QoL questionnaire (Short form-36)
Timeframe: Evaluation will be conducted at baseline, 6 months posttreatment, yearly through 3 years posttreatment
Change of score of Chinese Wechsler Intelligence Scale for Children
Timeframe: Score will be obtained at baseline, 6 months posttreatment, yearly through 3 years posttreatment

Secondary (2)

3-year overall survival
Short-term adverse effects of treatments

Arms and interventions

iGCTSExperimental

Stratum I (Germinoma) Patients who achieved complete response after induction chemotherapy will receive WVI 2400cGy/15f plus primary boost 640cGy/4f. Stratum II (NGGCTs) At the time of response evaluation before radiotherapy, those with complete response or residue disease \<1.5cm will receive WVI 3060cGy/17f plus primary boost 2340cGy/13f.

Radiation: Whole-ventricle irradiation

Drugs: Carboplatin/etoposide, Ifosfamide/cisplatin/etoposide

Procedures: Second-look surgery

Sites

1 site in 1 country

  • Beijing Tiantan HospitalBeijing, China